Ghana vs Israel: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Israel
100.0%
in 2024
Ghana rank
1st
Israel rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Israel
How they compare
Ghana currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 16 shared years of data; in 2005 it was Israel ahead.
Ghana ranks 1st and Israel ranks 1st of 180 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and Israel in 2.
Head to head by decade
| Decade | Ghana | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 80.5% | 73.8% | Israel |
| 2010s | 64.7% | 59.6% | 5.1% | Ghana |
| 2020s | 98.6% | 100.0% | 1.4% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Israel?
- Ghana, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Israel?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Israel?
- 16 years are reported by both, from 2005 to 2024.
- How do Ghana and Israel rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Israel ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.